AzTrials
AzTrials

Swallowing Disorder.Other SpecifiedNCT07765043

Electromagnetic Therapy for Cervicogenic Dysphagia

A study testing The pulsed electromagnetic field treatment program plus the swallowing resistance training program in people with Swallowing Disorder.Other Specified, run by Umm Al-Qura University at 1 site in Saudi Arabia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cervicogenic dysphagia (CD) is a swallowing disorder in patients with cervicogenic pathology. Pulsed electromagnetic therapy (PEMT) is a widely utilized therapeutic modality. Objective: To investigate the effects of PEMT on swallowing function (SF) and dysphagia handicapping effects in patients with CD. Read more about this study

Who is it for?
Ages 50 to 60 years
Conditions the study is for
Swallowing Disorder.Other Specified
What is being tested?
The pulsed electromagnetic field treatment program plus the swallowing resistance training program
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteSaudi Arabia
Study dates
1 Jul 2025to 25 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Individuals diagnosed with cervicogenic dysphagia and cervical spondylosis
  • Age 50-60 years.
  • Individuals with a sedentary lifestyle (less than 30 minutes of aerobic activities per day).
  • Signed the written consent

Who cannot join

  • Subjects diagnosed with rheumatological disease, cerebrovascular abnormalities
  • Subjects having a metal implant or previous cervical surgeries.
  • Subjects having received physical therapy programs for cervical spondylosis or dysphagia within the last 6 months.
  • Subjects with recent infection, cognitive impairments or dementia, cardiovascular instability, head or neck traumatic injuries, neurological disorders affecting swallowing (e.g., parkinsonism, stroke).
  • Subjects who received medications interfering with normal swallowing function (e.g., antiepileptics, antipsychotics, and antidepressant drugs).
  • Subjects who refused to provide the signed informed consent.

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site
  • Umm Al-Qura University

    Mecca, 24351

Other trials in Saudi Arabia

About this study

Official title: Efficacy of Electromagnetic Therapy in the Treatment of Cervicogenic Dysphagia: Randomized Single-blind Placebo-Control Study

Cervicogenic dysphagia (CD) is a swallowing disorder in patients with cervicogenic pathology. Pulsed electromagnetic therapy (PEMT) is a widely utilized therapeutic modality. Objective: To investigate the effects of PEMT on swallowing function (SF) and dysphagia handicapping effects in patients with CD. Methods: 40 volunteer participants (50-60 years old) with CD and cervical spondylosis were randomly and equally assigned to the study group (PEMT+swallowing resistance training program "SRTP") and control group (placebo PEMT+SRTP). Intervention: All participants received 3 sessions of SRTP (resisted chin tuck-in and resisted swallowing exercises) and 2 PEMT sessions (20 minutes of 20 Hz low frequency, 0.8 milli Tesla low intensity) per week for 8 weeks. Outcome Measures: The SF was evaluated using the swallow difficulty questionnaire "SDQ", and the dysphagia handicapping effects were evaluated using the dysphagia handicap index (DHI) pre-and post-study. Statistical analysis: Within-group comparisons were done using a paired t-test, and the between-group differences were examined using two-way ANOVA; a significant value was set at P<0.05.

Read the detailed description

Swallowing represents an integrated sensorimotor process accomplished by coordinated muscular actions. Cervical spine structures, under normal conditions, play an important role in maintaining coordinated swallowing.

The muscular and neural structures of the cervical spine are responsible for the coordinated movement of the larynx, pharynx, and hyoid bone during swallowing. Sensory information ascends from cervical structures to the brainstem, providing feedback to help synchronize the complex and harmonized contributions of the neck and throat muscles during swallowing. Disruption of this sensory feedback loop can result in coordination deficits and difficulty swallowing.

Biomechanical alterations or degenerative changes in the cervical spine can affect its position and stability. These alterations may further impact the surrounding neural and muscular structures' functions, resulting in a variety of alarming symptoms and dysfunctional patterns that predispose to mechanical obstruction and difficulty swallowing.

Cervicogenic dysphagia (CD) is an alarming disorder characterized by disturbed swallowing secondary to cervical structures dysfunction. Cervical spondylosis and associated pathological consequences can contribute to the development of CD. Cervical spine biomechanical alterations and malalignments, such as cervical kyphosis, a condition commonly encountered in cervical spondylosis, can predispose to pharyngeal dysfunction and difficult swallowing. The combined effects of neck muscular and articular dysfunctions represented in muscle weakness, poor cervical posture, and limited range of motion can disturb the cricopharyngeal sphincter action and the normal laryngeal function, ultimately predisposing to CD.

Although cure of dysphagia is not always possible, conservative approaches can provide an effective path to alleviate patients' complaints. A comprehensive dysphagia management program is not only important to restore normal swallowing function, but also to eliminate the economic burden and the dysphagia-related health hazards.

Low-frequency, low-intensity electromagnetic field therapy (EMT) is a safe, non-invasive therapeutic modality of clinical interest and effective applicability in the treatment of a variety of pathologies.

Although the effectiveness of pulsed electromagnetic field therapy (PEMFT) as a safe and effective therapeutic modality was investigated in a variety of cervical pathologies, there is a lack of evidence supporting the effectiveness of PEMFT in the treatment of patients with cervicogenic dysphagia.

Considering the reported safety and effectiveness of PEMFT therapy in the treatment of different pathologies, this study aimed to investigate the effects of PEMFT therapy on swallowing function and the dysphagia handicapping effects in patients with CD.

Being tested
The pulsed electromagnetic field treatment program plus the swallowing resistance training program, The placebo pulsed electromagnetic field treatment program plus the swallowing resistance training program
Keywords
Deglutition, Electromagnetic Therapy, Exercise
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The pulsed electromagnetic field treatment program plus the swallowing resistance training programBehavioural

    The pulsed electromagnetic field treatment program plus the swallowing resistance training program

  • The placebo pulsed electromagnetic field treatment program plus the swallowing resistance training programBehavioural

    The placebo pulsed electromagnetic field treatment program plus the swallowing resistance training program

Study groups in NCT07765043
Study groupRoleWhat they receive
Study group (received PEMFT + swallowing resistance training program; n=20)ExperimentalParticipants in the study group received the PEMFT treatment program in addition to the swallowing resistance training program "SRTP (which included the resisted chin tuck-in and the resisted swallowing exercises).
Receives: Behavioral: The pulsed electromagnetic field treatment program plus the swallowing resistance training program
Control group (received placebo PEMFT + swallowing resistance training program; n=20)Placebo comparatorParticipants in the control (Placebo comparator) group received the placebo PEMFT treatment program in addition to the swallowing resistance training program "SRTP (which included the resisted chin tuck-in and the resisted swallowing exercises).
Receives: Behavioral: The placebo pulsed electromagnetic field treatment program plus the swallowing resistance training program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Swallowing function

    Assessment of the swallowing function using the Swallowing Disturbance Questionnaire, composed of 15 self-reported items.

    Measured: Baseline and post-8 weeks

  2. The dysphagia handicapping effects

    The dysphagia handicapping effects assessment (using Dysphagia Handicap Index)

    Measured: Baseline and post 8 weeks.

Secondary outcomes (2)
  1. Pain intensity

    Assessment of pain intensity using the 10 cm visual analog scale (VAS)

    Measured: Baseline and post 8 weeks

  2. The forward head position

    The forward head position assessment (the craniovertebral angle)

    Measured: Baseline and post 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2026
  2. Study start1 Jul 2025
  3. Primary completion20 Mar 2026
  4. Study completion25 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This interventional study aimed to investigate the effects of Low-frequency, low-intensity electromagnetic field therapy on swallowing function and the dysphagia handicapping effects in patients with Cervicogenic dysphagia (CD). Forty participants matched the inclusion criteria, provided informed consent agreeing to participate in the study and publication of its results, and were randomly allocated to either the study group (received PEMFT + swallowing resistance training program "SRTP"; n=20) or the control group (received placebo PEMFT + SRTP; n=20). The study primary outcomes (swallowing function and dysphagia handicapping effect) and the secondary outcomes (pain and forward head position) were evaluated at the beginning and at the end of the study.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07765043
Sponsor's protocol ID
HAPO-02-K-012-2024-01-1956
Status last verified
Aug 2026
First submitted
10 Aug 2026
Last updated
18 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Required Institutional Ethical Committee approval first.

Questions about this trial

What is this clinical trial studying?

A study testing The pulsed electromagnetic field treatment program plus the swallowing resistance training program in people with Swallowing Disorder.Other Specified, run by Umm Al-Qura University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Swallowing function (time frame: Baseline and post-8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in